M&A activity in the pharmaceutical industry in Australia remained flat in 2023

In value terms, M&A activity in Australia decreased by 41% in Q2 2023 compared with the previous quarter’s total of $846.7m and rose by 46% as compared to Q2 2022. Related deal volume remained flat in Q2 2023 versus the previous quarter and was 300% higher than in Q2 2022.

The top-ranked legal advisorss supporting these M&A deals in Australia Q2 2023 were Arnold Bloch Leibler; Baker & McKenzie; Hall & Wilcox with 1, 1, 1 deals respectively.

For further understanding of GlobalData’s Pharma Industry Mergers and Acquisitions Deals by Top Themes, buy the report here.

This content was updated on 18 July 2023

GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.

GlobalData’s Deals Database tracks global deal activity, including mergers, acquisitions, capital raising, strategic alliances, and licensing agreements. Proprietary analysis is used to group deals into key thematic areas and granular sectors across the world’s largest industries.

This analysis considers only announced and completed deals from the GlobalData financial deals database and excludes all terminated and rumoured deals. Deal type includes Acquisition, Asset transactions and Mergers.

EMA safety committee ramps up warning against use of topiramate during pregnancy

The European Medicines Agency’s safety committee has issued a new warning against using topiramate, a drug commonly used to treat epilepsy and migraines, during pregnancy.

September 2, 2023

Study shows depression increases disability risk in rheumatoid arthritis sufferers

The interactions between rheumatoid arthritis (RA) and major depressive disorder (MDD).

November 7, 2023

UCL researchers develop UK’s first national menopause education program

Details of two new courses to help individuals before and during the menopause have been published as part of the launch of the UK’s first

September 14, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.